New Zealand’s main share index moved down in tandem with international markets as technology, banking and healthcare shares slipped with investors still wary about more potential interest rate hikes.

New Zealand's main share index rose on Wednesday after Pacific Edge announced a US healthcare provider would now be able to order its cancer test more quickly and easily.

New Zealand's benchmark equities index rose on Monday as the United States looked down under for solutions to its critical shortage of infant formula, sending A2 Milk up more than 10%.

New Zealand’s benchmark equity index fell marginally on Friday, bringing the full week decline to roughly 1.8%.

New Zealand's benchmark share index declined on Thursday as earnings reports from Eroad, Rakon, and Pacific Edge failed to impress investors.

New Zealand’s benchmark equity index fell on Wednesday as its largest stock, Fisher & Paykel Healthcare, slipped almost 4% and the central bank said it would raise interest rates further.

New Zealand's main share index fell on Tuesday as declines among large companies more than offset a $200 million increase in Pushpay’s market value following takeover bid updates.

AFT Pharmaceuticals led New Zealand’s share market higher after its new painkiller helped double the company’s annual net profit.

Strong local earnings reports boosted New Zealand's benchmark equity index on Friday, even as global markets wobbled.

New Zealand's headline share index slipped on Thursday after key indices on Wall Street plunged overnight, after another big retailer reported poor earnings and set recession alarms ringing.

New Zealand shares generally rose on Wednesday following a rally on Wall Street overnight and boosted by a strong performance from NZ electricity stocks.

New Zealand shares edged lower with investors unable to shake growing concerns the global economy is headed towards a recession.

New Zealand's main share index moved lower on Monday as Ryman Healthcare fell out of a key index, even as global markets had a bounce after recent weakness.

One of the titans of New Zealand's capital markets, Brian Gaynor, passed away this morning after a brief illness.

It’s been a long week in the investment world as international markets struggled against rising interest rates and inflation fears which seeped through to drag down New Zealand’s benchmark index for another day – just as the kiwi dollar reached a two-year low.

New Zealand shares slid half a percent as the United States consumer price index data showed inflation is still running hotter than many had hoped.